单位(元)汇添富中证中药ETF联接(LOF)A(501011)利润表 |
报告期 |
2023/12/31 |
2023/6/30 |
2022/12/31 |
2022/12/1 |
收入 |
58,357,114 |
205,789,155 |
-189,082,886 |
-223,924,958 |
利息收入 |
355,297 |
207,742 |
42,544 |
1,996,022 |
其中:存款利息收入 |
355,297 |
207,742 |
42,009 |
427,768 |
债券利息收入 |
- |
- |
- |
- |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
- |
- |
- |
- |
投资收益 |
-2,193,595 |
5,186,717 |
70,658,264 |
-172,867,308 |
其中:股票投资收益 |
1,213,954 |
1,398,076 |
95,346,165 |
-202,003,201 |
基金投资收益 |
-3,423,905 |
3,769,591 |
-22,942,372 |
- |
债券投资收益 |
1,806 |
5,692 |
-4,589 |
1,253 |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
14,551 |
13,358 |
-1,740,940 |
29,134,641 |
公允价值变动收益 |
58,044,899 |
198,902,291 |
-261,206,422 |
-62,301,236 |
汇兑收益 |
- |
- |
- |
- |
其他收入 |
2,150,513 |
1,492,405 |
1,422,728 |
9,247,564 |
费用 |
3,128,623 |
1,638,555 |
581,882 |
19,383,809 |
管理人报酬 |
588,887 |
310,728 |
279,673 |
14,168,656 |
托管费 |
78,518 |
41,430 |
37,290 |
1,889,154 |
销售服务费 |
2,233,924 |
1,158,941 |
248,079 |
2,748,769 |
交易费用 |
- |
- |
- |
- |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
205,720 |
105,883 |
16,838 |
571,584 |
利润总额 |
55,228,491 |
204,150,600 |
-189,664,768 |
-243,308,767 |
减:所得税费用 |
- |
- |
- |
- |
净利润 |
55,228,491 |
204,150,600 |
-189,664,768 |
-243,308,767 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。